68Ga-NODAGA-Ac-Cys-ZEGFR:1907

N/A

Report date: 2025/10/20 14:27:14

NME

Base Information

Drug Name68Ga-NODAGA-Ac-Cys-ZEGFR:1907

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesHarbin Medical University

China Registration ClassN/A

Develop Information

Active CompaniesHarbin Medical University

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A